Results 61 to 70 of about 76,283 (157)
SAGE Open Medical Case ReportsThis case report describes, to our knowledge, the first known successful treatment of airborne allergic contact dermatitis to sesquiterpene lactone with upadacitinib in an adult patient.
Barbara Marzario +2 more
doaj +1 more source
Profile of pacritinib and its potential in the treatment of hematologic disorders
Journal of Blood Medicine, 2014 Eleftheria Hatzimichael, Evangelos Tsolas, Evangelos Briasoulis Department of Haematology, University Hospital of Ioannina, Ioannina, Greece Abstract: Pacritinib (previously known as SB-1518) is an innovative selective inhibitor of Janus kinase 2 and ...
Hatzimichael E, Tsolas E, Briasoulis E
doaj
Intramolecular regulation of Janus kinases
, 2017 Janus kinases (JAKs) are non-receptor tyrosine kinases that mediate signalling of around sixty different cytokines governing various biological processes from the regulation of the immune system, to control of haematopoiesis, metabolism, and development.
openaire +2 more sources
Advances in Janus kinase inhibitors for vitiligo. [PDF]
Front ImmunolWen X, Yang G, Xue J, Zhang L.
europepmc +1 more source
Biologics, Janus Kinase Inhibitors, and Cancer: The Comparator on Trial. [PDF]
Int J Rheum DisChang ST, Hsu TC.
europepmc +1 more source
Computational Repurposing of Janus Kinase Inhibitors as Potential Therapeutic Candidates for Alzheimer's Disease. [PDF]
Medicina (Kaunas)Nguyen LTH, Nguyen MT, Nguyen TU.
europepmc +1 more source
Janus Kinase Inhibitors in Atopic Dermatitis: A Global Bibliometric Analysis (2015-2025). [PDF]
J Clin Pract ResAktaş S +4 more
europepmc +1 more source
Janus kinase inhibitor and rituximab in rheumatoid arthritis: is it a safe combination? [PDF]
Rheumatol Adv PractRabee H, Mahto A.
europepmc +1 more source
A Discrete Choice Experiment of Clinician Preferences Among Attributes of Approved Janus Kinase Inhibitors for Alopecia Areata. [PDF]
Adv TherDel Rosso JQ +6 more
europepmc +1 more source